Dark

CAPS
Capstone Holding Corp. Common Stock
stock NASDAQ

At Close

Jul 30, 2026 10:45:39 AM EDT

0.2400USD+0.417%(0.0000)87,097

0.00Bid 0.00Ask 0.0000Spread

Pre-market

Jul 30, 2026 9:07:30 AM EDT

0.2425USD+1.042%(+0.0025)0

After-hours

Jul 31, 2026 4:00:30 PM EDT

0.2530USD0.000%(+0.2530)156

OverviewHistoricalExchangesShortsTrends

open chart

Market Cap

3.74M

Headquarters

Tempe, Arizona, USA

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

Next Earnings

Aug 21, 2026 (18d)

Last Split

Sep 10, 20191for1,000reverse

CAPS Stats

Avg. Vol. 10 Day

88,979

Avg. Vol. 30 Day

262,596

Market Cap

3,739,981

Shares Out.

15,203,173

On/Off Exchange

37%/63%

6 Month Beta

0.92

1 Year Beta

0.70

2 Year Beta

1.32

3 Year Beta

1.34

52 Week Low

0.23

52 Week High

2.07

SMA50

0.28

SMA200

0.60

1 Week

+1.65%

1 Month

-5.75%

3 Month

-39.71%

6 Month

-57.80%

1 Year

-83.43%

2 Year

-94.53%

5 Year

-98.88%

Profile

capstone therapeutics (otcqb: caps) is a clinical stage biotechnology company developing a family of new peptide drugs to serve cardiovascular patients with high cholesterol and triglyceride levels otherwise unaddressable through standard therapy. capstone holds an fda orphan drug designation for its lead molecule, aem-28, for homozygous familial hypercholesterolemia (hofh) and may also target indications in acute coronary syndrome, peripheral artery disease and type 2 diabetes.

CAPS Stock Summary

Capstone Holding Corp. Common Stock (NASDAQ:CAPS) stock price today is $0.2400, and today's volume is 87,097. CAPS is up 0.417% today. The 30 day average volume is 262,596. CAPS market cap is 3.74M with 15,203,173 shares outstanding.

.dark-mode .Bx3Klb{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .Bx3Klb{ color: #333333; background-color: white; border: 2px solid #333333; }CAPSCapstone Holding Corp. Common Stockstock NASDAQ

CAPS Stock Summary

CAPS
Capstone Holding Corp. Common Stock
stock NASDAQ